1. Home
  2. BNTC vs PERI Comparison

BNTC vs PERI Comparison

Compare BNTC & PERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • PERI
  • Stock Information
  • Founded
  • BNTC 1995
  • PERI 1999
  • Country
  • BNTC United States
  • PERI Israel
  • Employees
  • BNTC N/A
  • PERI N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • PERI EDP Services
  • Sector
  • BNTC Health Care
  • PERI Technology
  • Exchange
  • BNTC Nasdaq
  • PERI Nasdaq
  • Market Cap
  • BNTC 365.1M
  • PERI 412.5M
  • IPO Year
  • BNTC N/A
  • PERI 2006
  • Fundamental
  • Price
  • BNTC $13.06
  • PERI $9.71
  • Analyst Decision
  • BNTC Strong Buy
  • PERI Strong Buy
  • Analyst Count
  • BNTC 5
  • PERI 3
  • Target Price
  • BNTC $26.60
  • PERI $14.75
  • AVG Volume (30 Days)
  • BNTC 304.0K
  • PERI 353.8K
  • Earning Date
  • BNTC 11-14-2025
  • PERI 11-12-2025
  • Dividend Yield
  • BNTC N/A
  • PERI N/A
  • EPS Growth
  • BNTC N/A
  • PERI N/A
  • EPS
  • BNTC N/A
  • PERI N/A
  • Revenue
  • BNTC N/A
  • PERI $432,361,000.00
  • Revenue This Year
  • BNTC N/A
  • PERI N/A
  • Revenue Next Year
  • BNTC N/A
  • PERI $11.12
  • P/E Ratio
  • BNTC N/A
  • PERI N/A
  • Revenue Growth
  • BNTC N/A
  • PERI N/A
  • 52 Week Low
  • BNTC $9.10
  • PERI $7.00
  • 52 Week High
  • BNTC $17.15
  • PERI $11.79
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 39.49
  • PERI 52.08
  • Support Level
  • BNTC $12.47
  • PERI $9.52
  • Resistance Level
  • BNTC $13.94
  • PERI $11.24
  • Average True Range (ATR)
  • BNTC 1.27
  • PERI 0.35
  • MACD
  • BNTC -0.18
  • PERI 0.05
  • Stochastic Oscillator
  • BNTC 29.06
  • PERI 37.04

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About PERI Perion Network Ltd.

Perion Network Ltd is a technology company. It offers online advertising and search solutions to brands, agencies, and publishers through desktop, mobile, and social channels. It connects advertisers to consumers across digital advertising channels, including search advertising, social, display, video, digital audio, digital out of home (DOOH), and Connected TV (CTV) advertising. The company earns prime revenue from search advertising and display advertising services. It operates in the business segment of High Impact Advertising solutions. Geographically, the company generates a majority of its revenue from the United States and the rest from other regions.

Share on Social Networks: